JP2024536859A5 - - Google Patents
Info
- Publication number
- JP2024536859A5 JP2024536859A5 JP2024518776A JP2024518776A JP2024536859A5 JP 2024536859 A5 JP2024536859 A5 JP 2024536859A5 JP 2024518776 A JP2024518776 A JP 2024518776A JP 2024518776 A JP2024518776 A JP 2024518776A JP 2024536859 A5 JP2024536859 A5 JP 2024536859A5
- Authority
- JP
- Japan
- Prior art keywords
- chimeric receptor
- cancer
- receptor polypeptide
- genetically modified
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248629P | 2021-09-27 | 2021-09-27 | |
| US63/248,629 | 2021-09-27 | ||
| US202263399324P | 2022-08-19 | 2022-08-19 | |
| US63/399,324 | 2022-08-19 | ||
| PCT/US2022/077103 WO2023049933A1 (en) | 2021-09-27 | 2022-09-27 | Chimeric receptor polypeptides in combination with trans metabolism molecules that re-direct glucose metabolites out of the glycolysis pathway and therapeutic uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536859A JP2024536859A (ja) | 2024-10-08 |
| JP2024536859A5 true JP2024536859A5 (enExample) | 2025-10-06 |
Family
ID=83996759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518776A Pending JP2024536859A (ja) | 2021-09-27 | 2022-09-27 | 解糖経路からグルコース代謝産物を再誘導するトランス代謝分子と組み合わせたキメラ受容体ポリペプチド及びその治療的使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240390495A1 (enExample) |
| EP (1) | EP4408982A1 (enExample) |
| JP (1) | JP2024536859A (enExample) |
| KR (1) | KR20240069799A (enExample) |
| AU (1) | AU2022349103A1 (enExample) |
| CA (1) | CA3232833A1 (enExample) |
| IL (1) | IL311712A (enExample) |
| MX (1) | MX2024004009A (enExample) |
| WO (1) | WO2023049933A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7456638B2 (ja) * | 2018-08-14 | 2024-03-27 | ソティオ，リミティド ライアビリティ カンパニー | クレブス回路を調節するトランス代謝分子と組み合わせたキメラ抗原受容体ポリペプチド、及び、それらの治療的使用 |
| WO2024040207A1 (en) | 2022-08-19 | 2024-02-22 | Sotio Biotech Inc. | Genetically engineered natural killer (nk) cells with chimeric receptor polypeptides in combination with trans metabolism molecules and therapeutic uses thereof |
| WO2024040208A1 (en) | 2022-08-19 | 2024-02-22 | Sotio Biotech Inc. | Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof |
| WO2024215987A1 (en) | 2023-04-14 | 2024-10-17 | Sotio Biotech Inc. | IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES |
| EP4694916A1 (en) | 2023-04-14 | 2026-02-18 | SOTIO Biotech Inc. | Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists |
| WO2025038646A1 (en) * | 2023-08-14 | 2025-02-20 | Intellia Therapeutics, Inc. | Cd70 car-t compositions and methods for cell-based therapy |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
| GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
| US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
| US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
| AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
| US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
| WO1990007936A1 (en) | 1989-01-23 | 1990-07-26 | Chiron Corporation | Recombinant therapies for infection and hyperproliferative disorders |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| AU648261B2 (en) | 1989-08-18 | 1994-04-21 | Novartis Vaccines And Diagnostics, Inc. | Recombinant retroviruses delivering vector constructs to target cells |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| WO1993010218A1 (en) | 1991-11-14 | 1993-05-27 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Vectors including foreign genes and negative selective markers |
| GB9125623D0 (en) | 1991-12-02 | 1992-01-29 | Dynal As | Cell modification |
| FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
| EP0650370A4 (en) | 1992-06-08 | 1995-11-22 | Univ California | METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES. |
| CA2137361A1 (en) | 1992-06-10 | 1993-12-23 | W. French Anderson | Vector particles resistant to inactivation by human serum |
| GB2269175A (en) | 1992-07-31 | 1994-02-02 | Imperial College | Retroviral vectors |
| EP1024198A3 (en) | 1992-12-03 | 2002-05-29 | Genzyme Corporation | Pseudo-adenoviral vectors for the gene therapy of haemophiliae |
| EP0705344B8 (en) | 1993-06-24 | 2006-05-10 | Advec Inc. | Adenovirus vectors for gene therapy |
| AU7477394A (en) | 1993-07-30 | 1995-03-27 | University Of Medicine And Dentistry Of New Jersey | Efficient gene transfer into primary lymphocytes |
| AU687117B2 (en) | 1993-10-25 | 1998-02-19 | Canji, Inc. | Recombinant adenoviral vector and methods of use |
| US5756910A (en) | 1996-08-28 | 1998-05-26 | Burgett, Inc. | Method and apparatus for actuating solenoids in a player piano |
| WO1998022588A2 (en) | 1996-11-20 | 1998-05-28 | Introgen Therapeutics, Inc. | An improved method for the production and purification of adenoviral vectors |
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| AU2474700A (en) | 1998-12-01 | 2000-06-19 | Genentech Inc. | Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| WO2000063374A1 (en) | 1999-04-16 | 2000-10-26 | Celltech Therapeutics Limited | Synthetic transmembrane components |
| US7435596B2 (en) | 2004-11-04 | 2008-10-14 | St. Jude Children's Research Hospital, Inc. | Modified cell line and method for expansion of NK cell |
| ES2610356T3 (es) | 2009-02-03 | 2017-04-27 | Amunix Operating Inc. | Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CN103946952A (zh) | 2011-09-16 | 2014-07-23 | 宾夕法尼亚大学董事会 | 用于治疗癌症的rna改造的t细胞 |
| KR102308597B1 (ko) | 2013-10-17 | 2021-10-01 | 내셔널 유니버시티 오브 싱가포르 | 다중 종양에 대항하여 항체-의존성 세포 세포독성을 촉발시키는 키메라 수용체 |
| CA2972714A1 (en) | 2014-09-09 | 2016-03-17 | Unum Therapeutics | Chimeric receptors and uses thereof in immune therapy |
| EP3430036A4 (en) | 2016-03-18 | 2019-08-14 | Unum Therapeutics | MODIFIED CHIMERIC RECEPTORS AND USES IN IMMUNOTHERAPY |
| AU2018213407A1 (en) | 2017-01-30 | 2019-08-08 | Unum Therapeutics Inc. | Improved antibody-coupled T cell receptor constructs and therapeutic uses thereof |
| AU2019299439C1 (en) | 2018-07-03 | 2025-06-26 | Sotio Biotech, Inc. | Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof |
| JP7456638B2 (ja) | 2018-08-14 | 2024-03-27 | ソティオ，リミティド ライアビリティ カンパニー | クレブス回路を調節するトランス代謝分子と組み合わせたキメラ抗原受容体ポリペプチド、及び、それらの治療的使用 |
-
2022
- 2022-09-27 WO PCT/US2022/077103 patent/WO2023049933A1/en not_active Ceased
- 2022-09-27 US US18/695,383 patent/US20240390495A1/en active Pending
- 2022-09-27 KR KR1020247013967A patent/KR20240069799A/ko active Pending
- 2022-09-27 EP EP22797213.0A patent/EP4408982A1/en active Pending
- 2022-09-27 AU AU2022349103A patent/AU2022349103A1/en active Pending
- 2022-09-27 IL IL311712A patent/IL311712A/en unknown
- 2022-09-27 JP JP2024518776A patent/JP2024536859A/ja active Pending
- 2022-09-27 MX MX2024004009A patent/MX2024004009A/es unknown
- 2022-09-27 CA CA3232833A patent/CA3232833A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024536859A5 (enExample) | ||
| JP7106610B2 (ja) | 導入遺伝子の遺伝子タグおよびその使用方法 | |
| Zhang et al. | Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity | |
| JP2022169543A (ja) | 改善された養子ｔ細胞療法 | |
| JP2021536265A5 (enExample) | ||
| JP2021534740A5 (enExample) | ||
| KR102483822B1 (ko) | 태그된 키메라 이펙터 분자 및 그의 리셉터 | |
| RU2700765C2 (ru) | Способ и композиции для клеточной иммунотерапии | |
| US20190023764A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| US20190321404A1 (en) | Novel chimeric antigen receptor and use thereof | |
| JP2021505131A5 (enExample) | ||
| JP2021529559A5 (enExample) | ||
| JP2019531328A5 (enExample) | ||
| Fellermeier et al. | Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format | |
| JP2023549098A5 (enExample) | ||
| US12187776B2 (en) | Pooling signaling and costimulatory domains in B7H6 chimeric antigen receptor | |
| WO2018045034A1 (en) | Chimeric antigen receptors having gitr intracellular domain as co-stimulatory domain | |
| JP2024515920A5 (enExample) | ||
| CN117683139A (zh) | 组成型嵌合细胞因子受体及表达其的免疫细胞及应用 | |
| CN117202921A (zh) | 用于多种免疫细胞的单链和多链合成抗原受体 | |
| RU2024129913A (ru) | Клетки, имеющие нацеленный на солидную опухоль каркас, и их применение | |
| NZ772146A (en) | Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating krebs cycle and therapeutic uses thereof | |
| NZ772146B2 (en) | Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating krebs cycle and therapeutic uses thereof | |
| RU2822461C1 (ru) | Трансгенные генетические метки и способы применения | |
| HK40069668A (en) | Transgene genetic tags and methods of use |